Oncept IL-2

Unknown🇪🇺 European Union

EMA Page

Authorised Date: N/A
Approval ID: 965c1eba07f94dc2
Products: 1 listed
Opinion Adopted: N/A

Overview Summary

The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.

Therapeutic & Classification

Therapeutic Indication

N/A

Therapeutic Area (MeSH)

N/A

ATC Code

N/A

ATC Item

N/A

Pharmacotherapeutic Group

N/A

Active Substances

Active Substance (Summary)

Canarypox virus, strain vCP1338, expressing feline interleukin-2 gene, live

INN / Common Names

feline interleukin-2 recombinant canarypox virus (vCP1338 virus)

Active Substance Details

Active substance details are not yet available.

Quick Info

Approval ID965c1eba07f94dc2

Product NumberN/A

StatusAuthorised

Authorised DateN/A

Opinion AdoptedN/A

Revision #N/A

Names & Aliases

EMA Name

Oncept IL-2

Medicine Name

Oncept IL-2

Aliases

N/A

Regulatory Flags

Orphan medicineUnknown

Generic medicineUnknown

BiosimilarUnknown

Conditional approvalUnknown

Exceptional circumstancesUnknown

Accelerated assessmentUnknown

Additional monitoringUnknown

Advanced therapyUnknown

Source Links

EMA Source

No risk management plan link.

Back to EMA Approvals